Table 4 |
|||
|
GAD1 single nucleotide substitutions detected on mutation analysis and occurring in sequences submitted to NCBI SNP database and in the literature. This is not a definitive list, but includes those described at the time of the mutational analysis. *Nucleotide positions were not provided by Maestrini et al. [47]. |
|||
|
Source |
SNP position in mRNA, from the translational start site (bp) |
Gene position of SNP(bp) |
Amino acid change |
|
|
|||
|
(A)Lappalainen et al. (2002) |
A(-478)Del |
Exon 0 (73) |
No substitution |
|
(B)Lappalainen et al. (2002) |
G(-147)A |
Exon 0 (404) |
No substitution |
|
(C)Lappalainen et al. (2002) |
A(-39)C |
Exon 1 (25) |
No substitution |
|
(D)Spastic CP patients family B |
G(36)C |
Exon 1 (97) |
Ser(12)Cys |
|
(E)NCBI collated resource |
G(48)C |
Exon 1 (104) |
Pro(17)Ala |
|
(F)Control samples & family A NCBI collated resource |
T(110)C |
Exon 2 (29) |
No substitution |
|
(G)Kure et al. (1998) |
T(315)C |
Exon 4 (14) |
No substitution |
|
(H)Bu and Tobin (1994) Kure et al. (1998) |
A(407)G |
Exon 4 (105) |
No substitution |
|
(I)Maestrini et al. (2002)* |
G/C |
Intron 4 |
No substitution |
|
(J)NCBI collated resource |
C(696)T |
Exon 6 (56) |
No substitution |
|
(K)Lappalainen et al. (2002) |
T/Del |
Intron 7 (35) |
No substitution |
|
(L)In control samples Lappalainen et al. (2002) |
T/C |
Intron 8 (185) |
No substitution |
|
(M)Maestrini et al. (2002)* |
C/T |
Intron 9 |
No substitution |
|
|
|||
|
Lynex et al. BMC Neurology 2004 4:20 doi:10.1186/1471-2377-4-20 |
|||